评估与COVID-19相关的胃肠道穿孔风险:一个自我控制的案例系列研究
Takayuki Okura1, Sachiko Tanaka-Mizuno1,2, Toshiki Fukasawa1,3
1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
该研究发现,在被诊断为COVID-19的患者中,胃肠道穿孔的风险显著增加,特别是在诊断后的前两周内. 这凸显了需要考虑COVID-19作为这种严重疾病的潜在风险因素的必要性.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 有限的流行病学数据存在于COVID-19和胃肠道穿孔之间的关联.
- 之前的病例报告表明存在潜在联系,需要进一步调查.
研究的目的:
- 为了定量评估COVID-19诊断后胃肠道穿孔的风险.
- 为了确定与COVID-19相关的胃肠道穿孔相关的时间模式和风险因素.
主要方法:
- 采用了一种自我控制的案例系列 (SCCS) 研究设计.
- 利用了日本全国索赔数据库,涵盖了2020年3月至2022年10月的时间.
- 包括276名被诊断为COVID-19的患者,他们接受了胃肠道穿孔手术.
- 条件式波桑回归分析了COVID-19后4周风险期的发病率比率 (IRR).
主要成果:
- 在COVID-19诊断后的第一周 (6.62) 和第二周 (3.27) 观察到胃肠穿孔的显著升高的IRR.
- 风险在第三周和第四周下降 (IRR为1.45).
- 这种关联在各个年龄组中保持一致,但在女性患者中相比男性患者的比例较低.
结论:
- COVID-19与胃肠道穿孔的风险增加显著相关,特别是在最初的两周.
- 在评估胃肠道穿孔患者时,医疗保健提供者应将COVID-19视为潜在的风险因素.
- 进一步的研究可能会探索病毒感染和胃肠道并发症之间的潜在机制.
更多相关视频
00:08Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
相关概念视频
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
